Consultation with FDA and Termination of Notification - Manufacturers and Repackagers

Guidance for Industry on Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification

⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0910-0806 can be found here:

Documents and Forms

Document Name Document Type
FINAL GUIDANCE Suspect product notification.docx Other-Guidance
3911 Drug Notification FDA FORM 3911.pdf Form

Information Collection (IC) Details

IC Title:	Consultation with FDA and Termination of Notification - Manufacturers and Repackagers	Agency IC Tracking Number:	CDER

Is this a Common Form? No		IC Status: New

Obligation to Respond: Mandatory

CFR Citation:

Information Collection Instruments:

Document Type	Form No.	Form Name	Instrument File	URL	Available Electronically?	Can Be Submitted Electronically?	Electronic Capability
Other-Guidance			FINAL GUIDANCE Suspect product notification.docx		Yes	No	Paper Only
Form	3911	Drug Notification	FDA FORM 3911.pdf		Yes	No	Paper Only

Line of Business: Health

Subfunction: Health Care Services

Privacy Act System of Records
Title:	FR Citation:

Number of Respondents: 800	Number of Respondents for Small Entity: 0

Affected Public: Private Sector	Private Sector: Businesses or other for-profits

Percentage of Respondents Reporting Electronically: 100 %

	Approved	Program Change Due to Agency Discretion
Annual Number of Responses for this IC	800	800
Annual IC Time Burden (Hours)	800	800
Annual IC Cost Burden (Dollars)	0	0

Documents for IC

Title	Document	Date Uploaded
No associated records found

Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.